跳至主要内容
临床试验/NCT03509428
NCT03509428Unknown不适用

A Pragmatic Factorial Design Randomised Controlled Study to Assess the Efficacy of the Implementation of a Prehabilitation Programme in Patients Undergoing Elective Major Intra - Cavity Cancer Surgery in Wessex

University Hospital Southampton NHS Foundation Trust1 个研究点 分布在 1 个国家目标入组 1,560 人开始时间: 2018年3月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
1,560
试验地点
1
主要终点
Post-operative length of hospital stay

研究概览

简要总结

Trial Phase: Phase III: A multi-centre efficacy pragmatic factorial design randomised controlled trial with patient informed development and process evaluation

Indication: Patients undergoing major electively resectable intra - cavity cancer surgery with or without neoadjuvant cancer treatments (including chemotherapy (NAC), chemoradiotherapy (CRT), or immunotherapy).

Objective: To investigate the efficacy of a community based Structured Responsive Exercise-training Programme (SRETP) ± psychological support on surgical outcome by reducing postoperative length of stay (LOS) and complications.

Secondary Objective:

To investigate the efficacy of a community based Structured Responsive Exercise-training Programme (SRETP) ± psychological support to improve disease-free overall survival. Cardiopulmonary Exercise test (CPET) variables, physical activity, morbidity, radiological markers of sarcopenia, toxicity, tumour down-staging, tumour regression, disability adjusted survival (WHODAS) overall survival and quality of life (QoL).

详细描述

Rationale: Fitter patients have better surgical outcomes. Poor physical fitness measured objectively using cardiopulmonary exercise testing has been associated with increased LOS, increased morbidity and mortality in many patient cohorts undergoing major cancer surgery. Chemotherapy and radiotherapy have detrimental effects on physical fitness, which may in turn have a detrimental effect on the patients' ability to withstand surgery. Research suggests psychological factors including depression and self-efficacy (confidence to manage cancer-related problems) prior to surgery predict recovery trajectories in health-related quality of life up to 2 years after major surgery for colorectal cancer.

The aim is to investigate whether SRETP (Prehabilitation) ± psychological support prior to and during cancer treatment before major elective surgery reduces LOS, increases survival and improves their ability to self manage. Additionally, we aim to see if this intervention can bring about long-term behavioural change in relation to physical activity.

Trial Design: Phase III: A pragmatic factorial design randomised controlled to assess the effectiveness of a prehabilitation programme delivered prior to cancer treatments and/or major cancer surgery in patients undergoing elective intra-cavity major cancer surgery in Wessex.

Sample size: 1560

Intervention:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

盲法说明

Masking of CPET assessors and dual reporting, masking of personnel involved in outcome data collection, masking of sarcopenia assessors

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Male or female patients
  • •aged over 18 years old
  • •scheduled to have major intra-cavity cancer surgery with a curative intent, defined as thoracic, colorectal, oesophagogastric, urological and hepatobiliary (inc. pancreatic).
  • •surgery alone (unimodal)
  • •surgery combined (multimodal) with cancer treatments (neoadjuvant chemotherapy, chemoradiotherapy or immunotherapies).
  • •All patients deemed by the MDT as potentially curable or undergoing neoadjuvant cancer treatments prior to restaging and surgery.

排除标准

  • •Patients will be excluded if under the age of 18 years,
  • •if their tumour is considered surgically non- resectable,
  • •having absolute or relative contraindications to completing a CPET,
  • •patients are unable to perform CPET due to other coexisting acute illness or conditions (e.g. lower limb dysfunction),
  • •patients decline surgery,
  • •if their weight exceeds 145kg
  • •patients unable to give informed consent.
  • •Patients having >2 mm ST depression if symptomatic or 4 mm if asymptomatic or >1 mm ST elevation during any CPET will need to be withdrawn from study.

研究组 & 干预措施

Control

No Intervention

Usual care plus additional monitoring

SRETP

Experimental

Structured Responsive Exercise Training Programme (SRETP) prior to surgery

干预措施: SRETP (Behavioral)

Psychological support

Experimental

Psychological support prior to surgery

干预措施: Psychological support (Behavioral)

SRETP and psychological support

Experimental

Structured Responsive Exercise Training Programme (SRETP) and psychological support prior to surgery

干预措施: SRETP (Behavioral)

SRETP and psychological support

Experimental

Structured Responsive Exercise Training Programme (SRETP) and psychological support prior to surgery

干预措施: Psychological support (Behavioral)

结局指标

主要结局

Post-operative length of hospital stay

时间窗: up to 1 year

Date of hospital admission minus date of discharge would equal length of post-operative stay (LOS).

次要结局

  • Change in objectively measured cardiopulmonary exercise testing variables - Oxygen uptake at anaerobic threshold (ml/kg/min) and oxygen uptake at peak exercise (ml/kg/min)(up to 15 weeks)
  • Overall survival - 1(1 year post-operatively)
  • Post-operative morbidity -1(POMS at day 3,5,7 and 15.)
  • Mental well being -3(Baseline up to 1 year post-operatively)
  • Mental well being -5(Baseline up to 1 year post-operatively)
  • Complex health interventions evaluation(Baseline up to 1 year post-operatively)
  • Tumour outcomes -15(Baseline up to 1 year post-operatively)
  • Tumour outcomes -16(Baseline up to 1 year post-operatively)
  • Disability adjusted survival(Baseline up to 1 year post-operatively)
  • Overall survival -2(5 years post-operatively)
  • Physical activity -1(Baseline up to 1 year post-operatively)
  • Disease free survival(1 year post-operatively)
  • Post-operative morbidity -2(up to 1 year)
  • Physical activity -2(Baseline up to 1 year post-operatively)
  • Physical activity -3(Baseline up to 1 year post-operatively)
  • Physical activity -4(Baseline up to 1 year post-operatively)
  • Health related quality of life -1(Baseline up to 1 year post-operatively)
  • Health related quality of life -2(Baseline up to 1 year post-operatively)
  • Health related quality of life -3(Baseline up to 1 year post-operatively)
  • Mental well being -1(Baseline up to 1 year post-operatively)
  • Mental well being -2(Baseline up to 1 year post-operatively)
  • Mental well being -4(Baseline up to 1 year post-operatively)
  • Radiological markers of sarco-cachexia measured from routine CT scans(Baseline up to 1 year post-operatively)
  • Toxicity and adverse events(Baseline up to 1 year post-operatively)
  • Tumour outcomes -1(Baseline up to 1 year post-operatively)
  • Tumour outcomes -2(Baseline up to 1 year post-operatively)
  • Tumour outcomes -3(Baseline up to 1 year post-operatively)
  • Tumour outcomes -4(Baseline up to 1 year post-operatively)
  • Tumour outcomes -5(Baseline up to 1 year post-operatively)
  • Tumour outcomes -6(Baseline up to 1 year post-operatively)
  • Tumour outcomes -7(Baseline up to 1 year post-operatively)
  • Tumour outcomes -8(Baseline up to 1 year post-operatively)
  • Tumour outcomes -9(Baseline up to 1 year post-operatively)
  • Tumour outcomes -10(Baseline up to 1 year post-operatively)
  • Tumour outcomes -11(Baseline up to 1 year post-operatively)
  • Tumour outcomes -12(Baseline up to 1 year post-operatively)
  • Tumour outcomes -13(Baseline up to 1 year post-operatively)
  • Tumour outcomes -14(Baseline up to 1 year post-operatively)
  • Tumour microenvironment(Baseline up to 1 year post-operatively)
  • Nutrition -1(Baseline up to 1 year post-operatively)
  • Nutrition -2(Baseline up to 1 year post-operatively)
  • Nutrition -3(Baseline up to 1 year post-operatively)
  • Nutrition -4(Baseline up to 1 year post-operatively)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

The Wessex Fit-4-Cancer Surgery Trial | 临床试验